GlassScriptPhysician profile
Rachel Hensley
NPI 1265918122
$6,355.05
in general payments reported to CMS, 2019-2025
22 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,548 · 2020: $326 · 2021: $1,191 · 2022: $2,401 · 2023: $393 · 2024: $355 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,330.94 | 2019-2024 | Bioskin, Actishield, Prostep |
| Smith+Nephew, INC. | $511.46 | 2019-2023 | Oasis, Grafix, Pico |
| Integra Lifesciences Corporation | $191.11 | 2019-2022 | |
| Novus Surgical Solutions LLC | $185.60 | 2022 | |
| Abbvie INC. | $142.89 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $125.00 | 2021 | |
| Axogen | $110.81 | 2019 | |
| Tei Medical INC. | $97.95 | 2019 | |
| Zimmer Biomet Holdings, INC. | $95.98 | 2019 | |
| Djo, LLC | $82.05 | 2021 | |
| Fortis Surgical, LLC | $78.70 | 2021-2024 | |
| Paratek Pharmaceuticals, INC. | $66.40 | 2023-2025 | Nuzyra |
| Trice Medical, INC. | $61.57 | 2023 | |
| Kerecis Limited | $58.29 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Trilliant Surgical LLC. | $51.73 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $44.09 | 2025 | Intellis Adaptivestim, Inceptiv |
| Lifenet Health | $27.77 | 2025 | Theragenesis Wound Matrix |
| In2bones USA, LLC | $22.36 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.40 | 2025 | |
| Reprise Biomedical, INC. | $17.21 | 2025 | Miro3d |
| Convatec INC. | $16.87 | 2024 | |
| Heron Therapeutics, INC. | $14.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Hensley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.